These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31665230)

  • 1. Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.
    Häusler D; Torke S; Peelen E; Bertsch T; Djukic M; Nau R; Larochelle C; Zamvil SS; Brück W; Weber MS
    Brain; 2019 Dec; 142(12):e72. PubMed ID: 31665230
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.
    Smolders J; Damoiseaux J; Hupperts R
    Brain; 2019 Dec; 142(12):e71. PubMed ID: 31665228
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypercalcaemia due to Hypervitaminosis D in a Self-Supplementing Multiple Sclerosis Patient: A Case Report.
    Duffy E; Brassill MJ
    Ir Med J; 2019 Jun; 112(6):953. PubMed ID: 31538442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
    Marcus JF; Shalev SM; Harris CA; Goodin DS; Josephson SA
    Arch Neurol; 2012 Jan; 69(1):129-32. PubMed ID: 22232355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply - Letter to the Editor - Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial.
    Stangl GI
    Clin Nutr; 2016 Dec; 35(6):1584. PubMed ID: 27601298
    [No Abstract]   [Full Text] [Related]  

  • 7. High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.
    Häusler D; Torke S; Peelen E; Bertsch T; Djukic M; Nau R; Larochelle C; Zamvil SS; Brück W; Weber MS
    Brain; 2019 Sep; 142(9):2737-2755. PubMed ID: 31302671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D supplementation in multiple sclerosis - Can be done something more?
    Tutor JC
    Med Hypotheses; 2019 Aug; 129():109256. PubMed ID: 31371069
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurofilament Light Chain Determination: Referee for Future Vitamin D3 Supplementation in Multiple Sclerosis?
    Goischke HK
    Neuroimmunomodulation; 2022; 29(4):520-522. PubMed ID: 35139509
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D
    Smolders J; Mimpen M; Oechtering J; Damoiseaux J; van den Ouweland J; Hupperts R; Kuhle J
    Acta Neurol Scand; 2020 Jan; 141(1):77-80. PubMed ID: 31657006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D intoxication due to an erroneously manufactured dietary supplement in seven children.
    Kara C; Gunindi F; Ustyol A; Aydin M
    Pediatrics; 2014 Jan; 133(1):e240-4. PubMed ID: 24298009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
    Kampman MT; Steffensen LH; Mellgren SI; Jørgensen L
    Mult Scler; 2012 Aug; 18(8):1144-51. PubMed ID: 22354743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.
    von Restorff C; Bischoff-Ferrari HA; Theiler R
    Bone; 2009 Oct; 45(4):747-9. PubMed ID: 19539796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25 hydroxyvitamin D profile after single large oral doses of cholecalciferol (vitamin D3) in medical staff in North India: a pilot study.
    Priyambada L; Bhatia V; Singh N; Bhatia E
    J Postgrad Med; 2014; 60(1):52-6. PubMed ID: 24625940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis.
    Kimball SM; Burton JM; O'Connor PG; Vieth R
    Clin Biochem; 2011 Jul; 44(10-11):930-2. PubMed ID: 21570386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D3 Supplementation and Bone Health-Reply.
    Rosendahl J; Valkama S; Andersson S
    JAMA Pediatr; 2018 Dec; 172(12):1202-1203. PubMed ID: 30357261
    [No Abstract]   [Full Text] [Related]  

  • 17. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
    Avasarala J; Sotirchos ES; Bhargava P; Calabresi PA
    Neurology; 2016 Jul; 87(4):445-6. PubMed ID: 27462039
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
    Golan D; Miller A; Sotirchos ES; Bhargava P; Calabresi PA
    Neurology; 2016 Jul; 87(4):446. PubMed ID: 27462040
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
    Kantor D; Sotirchos ES; Calabresi PA
    Neurology; 2016 Sep; 87(13):1424. PubMed ID: 27672169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.